• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Acutaas Chemicals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
543349
INE00FF01025
203.7819344
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ACUTAAS
77.34
28322.09
EPS(TTM)
Face Value()
Div & Yield %
44.73
5
0.07
 

Tilak Ventures standalone net profit rises 151.63% in the March 2026 quarter
May 21,2026
Net profit of Tilak Ventures rose 151.63% to Rs 3.85 crore in the quarter ended March 2026 as against Rs 1.53 crore during the previous quarter ended March 2025. Sales rose 120.09% to Rs 14.02 crore in the quarter ended March 2026 as against Rs 6.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 53.43% to Rs 9.62 crore in the year ended March 2026 as against Rs 6.27 crore during the previous year ended March 2025. Sales rose 43.67% to Rs 30.43 crore in the year ended March 2026 as against Rs 21.18 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales14.026.37 120 30.4321.18 44
OPM %49.0018.52 -27.6717.33 -
PBDT5.742.43 136 13.698.53 60
PBT5.742.43 136 13.688.52 61
NP3.851.53 152 9.626.27 53